中国输血设备市场投资潜力分析与发展前景建议报告2026-2032年版 【出版机构】：鸿晟信合研究院 【内容部分有删减·详细可参鸿晟信合研究院出版完整信息！】 1 输血设备市场概述 1.1 产品定义及统计范围 1.2.2 容量输液泵 1.2.3 重力输液泵 1.3 从不同应用，输血设备主要包括如下几个方面 1.3.1 中国不同应用输血设备增长趋势2021 VS 2025 VS 2032 1.3.2 医院 1.3.3 门诊手术中心 1.3.4 透析中心 1.3.5 其他 1.4 中国输血设备发展现状及未来趋势（2021-2032） 1.4.1 中国市场输血设备收入及增长率（2021-2032） 1.4.2 中国市场输血设备销量及增长率（2021-2032） 2 中国市场主要输血设备厂商分析 2.1 中国市场主要厂商输血设备销量及市场占有率 2.1.1 中国市场主要厂商输血设备销量（2021-2026） 2.2.3 2025年中国市场主要厂商输血设备收入排名 2.3 中国市场主要厂商输血设备价格（2021-2026） 2.4 中国市场主要厂商输血设备总部及产地分布 2.5 中国市场主要厂商成立时间及输血设备商业化日 ...

Core Viewpoint - Faruqi & Faruqi, LLP is investigating potential claims against KBR, Inc. related to alleged violations of federal securities laws, specifically concerning misleading statements about the company's operations and the Global Household Goods Contract with the U.S. Department of Defense [1][3]. Group 1: Legal Investigation - The investigation focuses on claims that KBR and its executives made false or misleading statements regarding the HomeSafe Alliance's ability to fulfill the Global Household Goods Contract, despite known concerns from TRANSCOM [3]. - Investors are reminded of the November 18, 2025 deadline to seek the role of lead plaintiff in a federal securities class action against KBR [1][5]. Group 2: Stock Performance Impact - Following the announcement of TRANSCOM's notice to terminate the Global Household Goods Contract, KBR's stock price fell by $3.85, or 7.29%, closing at $48.93 on June 20, 2025, and further declined by $1.30, or 2.65%, to close at $47.63 on June 23, 2025 [4]. Group 3: Investor Participation - Any member of the putative class may move the Court to serve as lead plaintiff or choose to remain an absent class member, with their ability to share in any recovery unaffected by this decision [5]. - Faruqi & Faruqi encourages individuals with information regarding KBR's conduct, including whistleblowers and former employees, to come forward [5].

Core Viewpoint - Rosen Law Firm has announced the filing of a class action lawsuit on behalf of purchasers of Marex Group plc securities during the specified Class Period, indicating potential legal issues surrounding the company's financial disclosures and practices [1][5]. Group 1: Class Action Details - The class action lawsuit is on behalf of purchasers of Marex securities between May 16, 2024, and August 5, 2025, and a previous class action has already been filed [1]. - Investors who purchased Marex securities during the Class Period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - Interested parties can join the class action by submitting a form or contacting the law firm directly, with a deadline to serve as lead plaintiff set for December 8, 2025 [3][6]. Group 2: Allegations Against Marex - The lawsuit alleges that Marex made materially false and misleading statements and failed to disclose critical information, including the sale of over-the-counter financial instruments to itself and inconsistencies in financial statements [5]. - It is claimed that Marex's financial statements could not be relied upon due to these issues, leading to misleading positive statements about the company's business and operations [5].

Core Viewpoint - Rosen Law Firm is investigating potential securities claims on behalf of shareholders of Brunello Cucinelli S.p.A due to allegations of materially misleading business information issued to the investing public [1]. Group 1: Investigation Details - The investigation is prompted by a report from Morpheus Research, which claims that Brunello Cucinelli misrepresented the status of its Russian business operations, stating that its Russian store locations were shut while allegedly continuing to conduct business in Russia [4]. - Following the publication of this report, Brunello Cucinelli's American Depositary Receipts (ADRs) experienced a significant decline of 17.8% on September 25, 2025 [5]. Group 2: Class Action Information - Shareholders who purchased Brunello Cucinelli securities may be entitled to compensation through a class action lawsuit, with no out-of-pocket fees or costs due to a contingency fee arrangement [2]. - Interested parties can join the prospective class action by submitting a form or contacting the Rosen Law Firm directly for more information [3]. Group 3: Rosen Law Firm's Credentials - The Rosen Law Firm has a strong track record in securities class actions, having achieved the largest securities class action settlement against a Chinese company at the time and consistently ranking among the top firms for securities class action settlements since 2013 [6]. - In 2019, the firm secured over $438 million for investors, showcasing its capability in recovering significant amounts for its clients [6].